Jennell C. Bilek | Iain A. McIntyre | Saukshmya Trichi

Carlson Caspers represented Teva in this Hatch-Waxman patent litigation concerning seven patents directed to formulations and uses of memantine extended-release (Namenda XR®).  After all of the other generic drug company defendants settled, our attorneys represented Teva as the sole remaining defendant at trial.  We achieved a successful settlement for our client after trial.